X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (607) 607
mart-1 antigen (415) 415
index medicus (279) 279
female (239) 239
melanoma (222) 222
male (216) 216
neoplasm proteins - metabolism (208) 208
melanoma - metabolism (194) 194
immunohistochemistry (190) 190
melanoma - pathology (181) 181
middle aged (178) 178
oncology (169) 169
melanoma - immunology (168) 168
antigens, neoplasm (163) 163
mart-1 antigen - metabolism (155) 155
adult (154) 154
neoplasm proteins - immunology (150) 150
antigens, neoplasm - metabolism (146) 146
immunology (141) 141
aged (128) 128
skin neoplasms - pathology (127) 127
skin neoplasms - metabolism (123) 123
pathology (115) 115
immunotherapy (109) 109
t-lymphocytes, cytotoxic - immunology (106) 106
animals (105) 105
antigens, neoplasm - immunology (105) 105
malignant-melanoma (104) 104
dermatology (103) 103
neoplasm proteins - genetics (100) 100
cd8-positive t-lymphocytes - immunology (97) 97
biomarkers, tumor - metabolism (94) 94
expression (93) 93
metastatic melanoma (85) 85
medicine, research & experimental (84) 84
mice (82) 82
melanoma-specific antigens (81) 81
s100 proteins - metabolism (78) 78
dendritic cells - immunology (77) 77
diagnosis, differential (76) 76
lymphocytes (76) 76
tumor cells, cultured (76) 76
dendritic cells (75) 75
cancer (74) 74
cell line, tumor (73) 73
melanoma - therapy (73) 73
cd8-positive t-lymphocytes - metabolism (71) 71
mart-1 (64) 64
melanoma - diagnosis (64) 64
antigens, neoplasm - genetics (63) 63
gp100 melanoma antigen (63) 63
tumors (62) 62
melanocytes - metabolism (61) 61
cells, cultured (59) 59
reverse transcriptase polymerase chain reaction (57) 57
melanoma - secondary (56) 56
monophenol monooxygenase - metabolism (56) 56
melanoma-specific antigens - metabolism (55) 55
aged, 80 and over (54) 54
dendritic cells - metabolism (54) 54
flow cytometry (54) 54
in-vitro (53) 53
mart-1 antigen - immunology (53) 53
t-lymphocytes, cytotoxic - metabolism (53) 53
melan-a (52) 52
melanoma - genetics (51) 51
tyrosinase (51) 51
diagnosis (50) 50
antigen (49) 49
article (49) 49
tumor-infiltrating lymphocytes (49) 49
analysis (48) 48
in-vivo (48) 48
hla-a2 antigen - immunology (47) 47
antigens (46) 46
identification (46) 46
peptide fragments - immunology (46) 46
skin neoplasms - diagnosis (45) 45
vaccination (45) 45
cells (44) 44
neoplasm proteins - biosynthesis (44) 44
interferon-gamma - metabolism (43) 43
mart-1 antigen - genetics (43) 43
melanocytes - pathology (43) 43
t cells (43) 43
metastasis (42) 42
cell biology (41) 41
epitopes, t-lymphocyte - immunology (41) 41
neoplasm proteins - analysis (41) 41
peptides (41) 41
t-lymphocytes - immunology (41) 41
abridged index medicus (40) 40
peripheral-blood (40) 40
amino acid sequence (39) 39
antigen presentation (39) 39
cell proliferation (39) 39
cell line (38) 38
hla-a2 antigen - metabolism (38) 38
prognosis (38) 38
biomarkers, tumor - analysis (37) 37
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Immunology, ISSN 0022-1767, 04/2015, Volume 194, Issue 7, pp. 3487 - 3500
TCR alpha- and beta-chains cooperatively recognize peptide -MHC complexes. It has been shown that a "chain-centric" TCR hemichain can, by itself, dictate... 
METASTATIC MELANOMA | CANCER REGRESSION | SELF-PEPTIDE | ENHANCED ANTITUMOR-ACTIVITY | T-CELL-RECEPTOR | HIGH-AFFINITY | ANTIGEN-PRESENTING CELLS | GENE-TRANSFER | IMMUNOLOGY | DIRECTED EVOLUTION | MOLECULAR-BASIS | Recombinant Fusion Proteins - immunology | T-Lymphocyte Subsets - immunology | Complementarity Determining Regions - genetics | Receptors, Antigen, T-Cell - chemistry | HLA-A2 Antigen - genetics | Humans | Protein Multimerization | Epitopes, T-Lymphocyte - genetics | Recombinant Fusion Proteins - metabolism | Complementarity Determining Regions - chemistry | MART-1 Antigen - metabolism | Peptide Fragments - immunology | Epitopes, T-Lymphocyte - immunology | Complementarity Determining Regions - metabolism | Peptide Fragments - genetics | MART-1 Antigen - chemistry | Amino Acid Sequence | Cell Line | Peptide Fragments - metabolism | Transduction, Genetic | HLA-A2 Antigen - immunology | Receptors, Antigen, T-Cell - metabolism | Immunophenotyping | Receptors, Antigen, T-Cell, alpha-beta - genetics | Epitopes, T-Lymphocyte - chemistry | HLA-A2 Antigen - chemistry | Peptide Fragments - chemistry | T-Lymphocyte Subsets - metabolism | MART-1 Antigen - genetics | Cell Line, Tumor | Protein Binding | Recombinant Fusion Proteins - genetics | Receptors, Antigen, T-Cell - genetics | Receptors, Antigen, T-Cell, alpha-beta - metabolism
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e40311
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells.... 
METASTATIC MELANOMA | HUMAN TUMOR-ANTIGEN | HLA-A2 MELANOMAS | B16 MELANOMA | MULTIDISCIPLINARY SCIENCES | IN-VIVO | APOPTOTIC CELLS | VACCINATION | PHASE-II | CROSS-PRESENTATION | LYMPHOCYTES | MART-1 Antigen - immunology | Melanoma - metabolism | Gamma Rays | HLA-A2 Antigen - immunology | Antigen Presentation - radiation effects | Dendritic Cells - immunology | Humans | Phagocytosis - immunology | Gene Expression Regulation, Neoplastic - immunology | Interferon-gamma - metabolism | Antigen Presentation - immunology | Phagocytosis - radiation effects | Microscopy, Confocal | Macrophages - metabolism | Melanoma - immunology | Interferon-gamma - immunology | CD8-Positive T-Lymphocytes - metabolism | Cell Line, Tumor | Gene Expression Regulation, Neoplastic - radiation effects | MART-1 Antigen - biosynthesis | HLA-A2 Antigen - metabolism | CD8-Positive T-Lymphocytes - immunology | Dendritic Cells - metabolism | Macrophages - immunology | Biotechnology | Peptides | CD8 antigen | Antigen processing | Irradiated | Clinical trials | Confocal microscopy | Mesothelioma | Lymphocytes T | Vaccines | Macrophages | Cancer therapies | Phagocytes | Killer cells | Lymphocytes | Immunotherapy | Stains | Antigen presentation | Antigens | Medical research | Dendritic cells | Granulocyte-macrophage colony-stimulating factor | Tumor cells | Melanoma | BCG | Cultures | Patients | Bladder cancer | Microscopy | Antigen-presenting cells | Antigen (tumor-associated) | Cell lines | Antitumor activity | Interferon | Histocompatibility antigen HLA | Phagocytosis | Tumors | Cancer | Apoptosis | Antibodies | Melanocytes | MART-1 antigen | gamma Radiation | gamma -Interferon
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 10/2012, Volume 287, Issue 44, pp. 37269 - 37281
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 05/2014, Volume 134, Issue 5, pp. 1369 - 1377
Journal Article
Journal of Immunology, ISSN 0022-1767, 08/2010, Volume 185, Issue 4, pp. 2600 - 2610
Journal Article
Journal of Immunology, ISSN 0022-1767, 10/2012, Volume 189, Issue 7, pp. 3538 - 3547
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 2010, Volume 225, Issue 1, pp. 22 - 33
Abstract Immunotherapy is a promising new treatment for patients suffering from glioma, in particular glioblastoma multiforme (GBM). However, tumour cells use... 
Neurology | Allergy and Immunology | IDO | Immunomodulation | Immunotherapy | Glioblastoma | TGF-β | PDL-1 | T cells | GLIOMA-CELLS | FAS LIGAND | HLA-G EXPRESSION | PHASE-I/II TRIAL | IMMUNE ESCAPE | lmmunotherapy | IMMUNOLOGY | NEUROSCIENCES | MALIGNANT GLIOMA | TGF-beta | GROWTH-FACTOR-BETA | INTERFERON-GAMMA | CENTRAL-NERVOUS-SYSTEM | Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism | Fas Ligand Protein - metabolism | Flow Cytometry - methods | Transforming Growth Factor beta2 - metabolism | Humans | HLA Antigens - genetics | Interferon-gamma - metabolism | Indoleamine-Pyrrole 2,3,-Dioxygenase - pharmacology | Neoplasm Proteins - metabolism | RNA, Messenger - metabolism | Antigens, CD - metabolism | Histocompatibility Antigens Class I - metabolism | T-Lymphocytes - drug effects | Antigens, Neoplasm - metabolism | Cytotoxicity, Immunologic - drug effects | B7-H1 Antigen | Oligonucleotide Array Sequence Analysis - methods | Gene Expression Profiling - methods | Lectins - pharmacology | Histocompatibility Antigens Class I - genetics | HLA-G Antigens | HLA Antigens - metabolism | Gene Expression Regulation - drug effects | Glioblastoma - immunology | Glioblastoma - pathology | Cell Line, Tumor | Antigens, CD - pharmacology | MART-1 Antigen | T-Lymphocytes - immunology | Cell Proliferation - drug effects | HLA-A2 Antigen - metabolism | Cytotoxicity, Immunologic - immunology | Fas Ligand Protein - genetics | Interferon-gamma - pharmacology | Cell research | Histocompatibility antigens | Messenger RNA | HLA histocompatibility antigens | Lectins | Biochemistry | Transforming growth factors | Glioblastoma multiforme | Apoptosis | Cell Proliferation | Oligonucleotide Array Sequence Analysis | Histocompatibility Antigens Class I | Gene Expression Profiling | Life Sciences | Flow Cytometry | Immunology | Neoplasm Proteins | Transforming Growth Factor beta2 | Interferon-gamma | Antigens, Neoplasm | T-Lymphocytes | Gene Expression Regulation | Fas Ligand Protein | HLA-A2 Antigen | Indoleamine-Pyrrole 2,3,-Dioxygenase | HLA Antigens | RNA, Messenger | Antigens, CD | Cytotoxicity, Immunologic | Cancer
Journal Article
Molecular Therapy, ISSN 1525-0016, 09/2015, Volume 23, Issue 9, pp. 1541 - 1550
Journal Article
Biomaterials, ISSN 0142-9612, 09/2018, Volume 178, pp. 158 - 169
Journal Article